Center for Translationel Forskning

Medicin og biovidenskab

1. Type 2 Diabetes Mellitus 100%
2. Denmark 81%
3. Cohort Studies 78%
4. Observational Studies 68%
5. Vital Signs 60%
6. Coronavirus 54%
7. Randomized Controlled Trials 51%
8. Placebos 51%
9. Glucagon-Like Peptide-1 Receptor 44%
10. Mortality 43%
11. Glucose 42%
12. Severe Acute Respiratory Syndrome 41%
13. Hospital Emergency Service 38%
14. Prospective Studies 38%
15. Chronic Obstructive Pulmonary Disease 35%
16. Cross-Over Studies 33%
17. Hyperoxia 32%
18. Oxygen 30%
19. SARS Virus 28%
20. alpha-Synuclein 28%
21. Multiple System Atrophy 26%
22. Hypoglycemia 26%
23. Obesity 25%
24. Synucleins 23%
25. Ketones 23%
26. Quality of Life 23%
27. Synucleinopathies 23%
28. Cognition 22%
29. Pandemics 22%
30. Hospitalization 22%
31. Sensory Gating 22%
32. Mannose-Binding Lectin 21%
33. Hypoglycemic Agents 21%
34. Peptides 21%
35. Polypharmacy 20%
36. Parkinson Disease 20%
37. Early Warning Score 19%
38. Psoriatic Arthritis 19%
39. Sodium-Glucose Transport Proteins 19%
40. Occupational Groups 18%
41. Therapeutics 18%
42. Ketone Bodies 18%
43. Confidence Intervals 18%
44. Clinical Studies 17%
45. Glucagon 17%
46. Infections 17%
47. Antioxidants 17%
48. Delivery of Health Care 17%
49. Cognitive Dysfunction 16%
50. Brain 16%
51. gastric inhibitory polypeptide receptor 16%
52. Muscle Strength 16%
53. Dyspnea 15%
54. Vaccination 15%
55. Heart Failure 15%
56. Insulin 14%
57. Coronavirus Infections 14%
58. coronavirus receptor 14%
59. Glucagon-Like Peptide 1 14%
60. Acetylcysteine 14%
61. Type 1 Diabetes Mellitus 14%
62. Antibodies 14%
63. Pragmatic Clinical Trials 13%
64. Systemic Inflammatory Response Syndrome 13%
65. Health Personnel 13%
66. Prefrontal Cortex 13%
67. exendin (9-39) 13%
68. Systematic Reviews 13%
69. Prepulse Inhibition 13%
70. Respiratory Rate 13%
71. RNA 12%
72. Transcutaneous Blood Gas Monitoring 12%
73. Neurodegenerative Diseases 12%
74. Sepsis 12%
75. Passive Immunization 12%
76. Case-Control Studies 12%
77. Hydroxybutyrates 12%
78. Phenotype 12%
79. Asthma 12%
80. metabotropic glutamate receptor 2 12%
81. Registries 12%
82. Comorbidity 12%
83. Wounds and Injuries 11%
84. Perfusion Index 11%
85. Eating 11%
86. Geriatrics 11%
87. Liraglutide 11%
88. Seroepidemiologic Studies 11%
89. BCG Vaccine 10%
90. Hyperglycemia 10%
91. Short Bowel Syndrome 10%
92. Glucokinase 10%
93. Glycocalyx 10%
94. Equivalence Trials 10%
95. Appetite Regulation 10%
96. Gene Expression 10%
97. Hepcidins 10%
98. Rural Hospitals 10%
99. Dipeptidyl-Peptidase IV Inhibitors 10%
100. Parvalbumins 10%